key: cord-0778276-6rd5tijj
authors: Deng, John Z.; Chan, Janine S.; Potter, Alexandra L.; Chen, Ya-Wen; Sandhu, Harpal S.; Panda, Nikhil; Chang, David C.; Yang, Chi-Fu Jeffrey
title: The Risk of Postoperative Complications After Major Elective Surgery in Active or Resolved COVID-19 in the United States
date: 2021-11-18
journal: Ann Surg
DOI: 10.1097/sla.0000000000005308
sha: c05a57bb80a1224c9874d892e1d32f1cc0a0bfa4
doc_id: 778276
cord_uid: 6rd5tijj

To assess the association between the timing of surgery relative to the development of Covid-19 and the risks of postoperative complications. SUMMARY BACKGROUND DATA: It is unknown whether patients who recovered from Covid-19 and then underwent a major elective operation have an increased risk of developing postoperative complications. METHODS: The risk of postoperative complications for patients with Covid-19 undergoing 18 major types of elective operations in the Covid-19 Research Database was evaluated using multivariable logistic regression. Patients were grouped by time of surgery relative to SARS-CoV-2 infection; that is, surgery performed: (1) before January 1, 2020 (“pre-Covid-19”), (2) 0 to 4 weeks after SARS-CoV-2 infection (“peri-Covid-19”), (3) 4 to 8 weeks after infection (“early post-Covid-19”), and (4) ≥8 weeks after infection (“late post-Covid-19”). RESULTS: Of the 5479 patients who met study criteria, patients with peri-Covid-19 had an elevated risk of developing postoperative pneumonia [adjusted odds ratio (aOR), 6.46; 95% confidence interval (CI): 4.06–10.27], respiratory failure (aOR, 3.36; 95% CI: 2.22–5.10), pulmonary embolism (aOR, 2.73; 95% CI: 1.35–5.53), and sepsis (aOR, 3.67; 95% CI: 2.18–6.16) when compared to pre-Covid-19 patients. Early post-Covid-19 patients had an increased risk of developing postoperative pneumonia when compared to pre-Covid-19 patients (aOR, 2.44; 95% CI: 1.20–4.96). Late post-Covid-19 patients did not have an increased risk of postoperative complications when compared to pre-Covid-19 patients. CONCLUSIONS: Major, elective surgery 0 to 4 weeks after SARS-CoV-2 infection is associated with an increased risk of postoperative complications. Surgery performed 4 to 8 weeks after SARS-CoV-2 infection is still associated with an increased risk of postoperative pneumonia, whereas surgery 8 weeks after Covid-19 diagnosis is not associated with increased complications.

A s of July 2021, over 20 million people in the United States (U.S.) have recovered from coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 1,2 During active SARS-CoV-2 infection, many of these patients had pneumonia, 3,4 respiratory failure, 3, 5 arrhythmias, [6] [7] [8] [9] and thrombotic complications such as pulmonary embolism (PE) 10, 11 and deep vein thrombosis (DVT). [10] [11] [12] Over 60% of patients may continue to have persistent symptoms after these complications. [13] [14] [15] It is unclear whether patients who recovered from Covid-19 can undergo an elective major operation safely. Studies of elective 3, 5, 9, 16 or emergent 3,16 operations on Covid-19 patients during the perioperative period report pulmonary complications ranging from 24.2% to 51.2%, 3, 16, 17 thromboembolic events from 6.8% to 13.4%, 16, 18, 19 shock from 11% to 13.9%, 17, 19 and 30-day mortality from 9.1% to 32.6%. 3, [17] [18] [19] [20] However, there are few data on the risks of postoperative complications after surgery following recovery from Covid- 19 . The objective of this study is to assess the association between the timing of surgery relative to the development of Covid-19 and the risks of postoperative pulmonary complications and other major complications.

The data for this study were derived from Symphony Health through the Covid-19 Research Database. The Covid-19 Research Database is a pro-bono, public-private consortium composed of institutions that contribute de-identified data of patients with Covid-19. Symphony Health, a partnering institution, contains longitudinal patient data sources via its ''Integrated Dataverse'' that captures adjudicated prescription, medical, and hospital claims across the U.S. for all payment types, including commercial plans, Medicare Part D, cash, assistance programs, and Medicaid. Symphony Health is an open dataset from participating hospitals and health plans that utilize clearinghouses associated with Symphony Health. Data are continuously updated with new claims, with coverage beginning May 2019 and inclusion of over 1500 hospitals, 800 outpatient facilities, and 280 million patients at the time of this study.

All patients with a confirmed Covid- 19 Patients who underwent one operation based on Current Procedural Terminology codes were included. These operations are all considered major elective operations in the U.S., which include lung resection (lobectomy, pneumonectomy, and segmentectomy), esophagectomy, mastectomy, colorectal resection for cancer (colectomy and proctectomy), prostatectomy, pancreatic resections (Whipple, total pancreatectomy, and distal pancreatectomies), hepatectomy, gastrectomy, hip replacement, coronary artery bypass grafting, knee replacement, laminectomy, hysterectomy, spinal fusion, elective open repair of abdominal aortic aneurysm (AAA), elective endovascular repair of abdominal aortic aneurysm (EVAR), brain tumor resection, and carotid endarterectomy (Supplemental Digital Content Table S3 , http://links. lww.com/SLA/D523). Exclusion criteria included patients who underwent multiple operations and patients who did not have any of the above-specified operations. We specifically excluded operations that could have been performed for emergent reasons, including Caesarian section, cholecystectomy, appendectomy, colectomy for perforated diverticulitis, hernia repair in the setting of incarceration, AAA repair for ruptured aneurysm, and any type of trauma surgery. To assess the risk of postoperative complications among patients who underwent operations for more urgent reasons, a subgroup analysis was conducted. The operations included in this subgroup analysis were EVAR, open repair of AAA, carotid endarterectomy, gastrectomy, hepatectomy, lung resection, neurosurgical resection of tumor, pancreatic surgery, colorectal surgery, and esophagectomy.

Patients were categorized into four groups based on the time of surgery relative to the Covid-19 diagnosis date (Fig. 2) . The ''peri-Covid-19'' group was defined as surgery performed 0 to 4 weeks after the Covid-19 diagnosis date. These are patients with perioperative SARS-CoV-2 infection. The ''early post-Covid-19'' group was composed of patients who underwent surgery between 4 and 8 weeks after the Covid-19 diagnosis date. ''Late post-Covid-19'' was defined as surgery performed 8 weeks or greater after the Covid-19 diagnosis date.

For our control group, we selected patients who underwent surgery at least 30 days before their Covid-19 diagnosis date and had surgery between the dates of May 1, 2019 to January 1, 2020. This ''pre-Covid-19'' group was selected as our reference group because they had not been infected with SARS-CoV-2 before surgery and any 30-day postoperative complication they developed could not be attributed to sequelae of SARS-CoV-2 infection. For this ''pre-Covid-19'' control group, we did not select patients who never developed Covid-19 because patients who never developed Covid-19 during the pandemic may have a different racial, ethnic, socioeconomic, and/or geographic background from patients in the peri-Covid-19, early post-Covid-19 and late post-Covid-19. 21

The primary outcomes of interest for the present study were postoperative pneumonia and respiratory failure. Secondary outcomes included DVT, PE, arrhythmia, and sepsis (Supplemental Digital Content Table S4 , http://links.lww.com/SLA/D523).

Comorbidities were identified using ICD-10-CM codes for the following underlying conditions: diabetes, hypertension, chronic obstructive pulmonary disease, gastroesophageal reflux disease, obesity, coronary artery disease, congestive heart failure, chronic kidney disease, ulcerative colitis, Crohn disease, mild liver disease, severe liver disease, history of stroke, and depression (Supplemental Digital Content Table S5 , http://links.lww.com/SLA/D523).

Patient characteristics and unadjusted outcomes were assessed using Pearson chi-square test for categorical variables and t test or Wilcoxon Rank Sum test where appropriate for continuous variables. A multivariable logistic regression model was used to evaluate the risk of developing any postoperative complication, adjusting for covariates determined a priori to be clinically relevant. These covariates included time of surgery relative to Covid-19 diagnosis date, age, sex, race, first digit zip code region, diabetes, hypertension, chronic obstructive pulmonary disease, gastroesophageal reflux disease, obesity, coronary artery disease, congestive heart failure, chronic kidney disease, ulcerative colitis, Crohn disease, mild liver disease, severe liver disease, history of stroke, and depression. We also used separate multivariable logistic regression models to evaluate the risk of pneumonia, respiratory failure, PE, sepsis, DVT, arrhythmia, renal failure, and urinary tract infection, adjusting for covariates listed in Supplemental Digital Content Tables S4 and S5, http://links.lww.com/SLA/D523.

The dataset used for analysis was prepared using Snowflake (Snowflake Inc, San Mateo, CA). Statistical analysis was performed using STATA/MP software, version 16 

There were 5479 patients who met study criteria (Fig. 1) . Of these patients, 2621 (47.8%) patients underwent surgery before January 1, 2020, at least 30 days before being diagnosed with Covid-19 (''pre-Covid-19''), 780 (14.2%) patients underwent surgery 0 to 4 weeks after their Covid-19 diagnosis date (''peri-Covid-19''), 445 (8.1%) patients underwent surgery 4 to 8 weeks after their Covid-19 diagnosis date (''early post-Covid-19''), and 1633 (29.8%) patients underwent surgery 8 weeks or more after their Covid-19 diagnosis date (''late post-Covid-19'').

Supplemental Digital Content Table S1 , http://links.lww.com/ SLA/D523 details patient characteristics. The majority of patients had mild Covid-19 with only 0.4% and 0.9% having severe or critical Covid-19, respectively. Across all groups, the most common comorbidities were obesity and hypertension. The most common operation for the pre-Covid-19 group was hysterectomy, the most common operation for the peri-Covid-19 group was knee arthroplasty, and the most common operation for both the early and late post-Covid-19 groups was hysterectomy.

The postoperative outcomes for each group are detailed in Table 1 

We assessed the impact of timing of surgery relative to SARS-CoV-2 infection on the risk of developing postoperative complications among 5479 patients undergoing 18 types of common, major, elective In the coming months, the number of patients who have recovered from SARS-CoV-2 infection and require major surgery will continue to increase. Previous studies have shown that patients with perioperative SARS-CoV-2 infection who undergo surgery have an increased risk of postoperative complications and 30-day mortality. 3, 18, 22 However, there are only a few studies assessing the impact of the timing of elective major surgery relative to SARS-CoV-2 infection on the risk of postoperative complications. Thus far, there have only been two studies, one performed in Brazil 23 and one multicenter study of mostly European patients evaluating postoperative risk after recovery from Covid-19. 20 Baiocchi and colleagues 23 assessed the postoperative outcomes of 49 Brazilian patients who underwent delayed elective surgery after a confirmed preoperative diagnosis of asymptomatic Covid-19. The authors found that asymptomatic Covid-19 patients who underwent surgery delayed by a median of 25 days did not have an increased risk of postoperative complications when compared to patients with a negative preoperative Covid-19 test. The Covid-19 Surg Collaborative evaluated 3127 predominately European patients from 1674 hospitals and 116 countries who had a Covid-19 diagnosis and then underwent surgery after different timepoints (eg, within 2 weeks of diagnosis, 3 to 4 weeks, 5 to 6 weeks, and ! 7 weeks after diagnosis). The authors found that the pulmonary complication rate and the mortality rate were the lowest among patients who underwent surgery ! 7 weeks after diagnosis. Our findings, which pertain to elective major operations in the U.S., are consistent with the results first reported in these studies.

Of note, Baiocchi et al 23 and the Covid-19 Surg Collaborative included major and minor operations in their analysis, and the COVID-19 Surg Collaborative also included emergent operations and trauma surgeries. In the present study, we evaluated only elective major operations and did not include minor procedures or emergent operations in the analysis.

The findings from this study have important implications for surgical care as we begin to recover from the Covid-19 pandemic, which has caused widespread and numerous delays in surgical care. At the height of the Covid-19 pandemic, approximately 100,000 elective operations were canceled or postponed weekly in the U.S. 24 To avoid similar delays and cancellations during the recovery from the pandemic, evidence-based guidelines to safely restore surgical activity are greatly needed. In preparation for an increasing number of patients who have recovered from Covid-19 who subsequently require surgery, guidelines and preoperative protocols for the evaluation of these patients have been published. 25, 26 However, due to the limited data available to inform the timeframe of recovery, recommendations for delaying surgery are based largely on expert opinion or previous data from other post-viral syndromes. 25, 26 The findings from our study could inform future guidelines on the timing of surgery in patients with recent SARS-CoV-2 infection. Importantly, our findings suggest that for most patients with confirmed Covid-19, delaying surgery for approximately 8 weeks may reduce the risk of developing major postoperative complications. Based on these findings, we recommend delaying surgery, if possible, for at least 8 weeks after confirmed SARS-CoV-2 infection. However, it is important to note that for certain cancer patients, delayed surgical treatment during non-pandemic settings has been shown to be associated with worse overall survival when compared to timely surgical treatment. 27 As such, the balance between the risk of postoperative complications and the risk of worse overall survival associated with delayed surgical treatment should be carefully discussed in a multi-disciplinary setting before deciding on whether surgery should be delayed.

There are several limitations to our study. First, because of its retrospective study design, results are subject to residual confounding. Second, the Covid-19 research database did not have data on whether a patient with confirmed SARS-CoV2 infection was asymptomatic or symptomatic. Depending on the region in the U.S., anywhere from 18% to 45% of individuals with Covid-19 have been reported to be asymptomatic. [28] [29] [30] Given that our study includes a nationally representative sample of Covid-19 cases, we assume the percentage of asymptomatic Covid-19 cases in our study is similar in range. The Covid-19 research database did have data on Covid-19 severity [mild/moderate vs severe (eg, requiring supplemental oxygen) vs critical (eg, shock and ARDS)] and we were able to adjust by Covid-19 severity in our models. Third, we were not able to precisely determine when the patient developed Covid-19. In the present study, we used the date of the PCR test to estimate the Covid-19 diagnosis date; however, the patient could have been infected by SARS-CoV-2 or developed Covid-19 several days before this date. Fourth, the Covid-19 research database does not include mortality information and we were unable to assess the risk of 30-or 90-day mortality associated with surgery at different timepoints with respect to SARS-CoV-2 infection. Fifth, quality of life measures and long-term survival data were not captured in the database. Sixth, we were unable to assess preoperative measurements of frailty that may have been important in determining when a patient would be sufficiently recovered from Covid-19 to undergo surgery. The association between measurements of frailty and recovery from Covid-19 should be further investigated. In addition, future studies should evaluate how measurements of frailty could be used to inform preoperative assessments of surgical risk among patients recovered from Covid-19.

In conclusion, surgery performed during or near the time of SARS-CoV-2 infection is associated with an increased risk of developing postoperative complications, including postoperative pneumonia, respiratory failure, PE and sepsis. Surgery performed 4 to 8 weeks after confirmed SARS-CoV-2 infection continues to carry an elevated risk of developing postoperative pneumonia. However, surgery performed 8 weeks or later after confirmed SARS-CoV-2 infection is not associated with an increased risk of developing postoperative complications. Based on these findings, we recommend that the safe period for patients with recent SARS-CoV-2 infection in whom elective, nonemergent surgery is indicated should be at least 8 weeks after the first date of confirmed SARS-CoV-2 infection.

An interactive web-based dashboard to track COVID-19 in real time

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

Clinical characteristics of coronavirus disease 2019 in China

COVID-19 outbreak and surgical practice: unexpected fatality in perioperative period

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Clinical characteristics of Covid-19 in New York City

COVID-19 infection and cardiac arrhythmias

Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection

Thrombosis in hospitalized patients with COVID-19 in a New York City health system

Incidence of venous thromboembolism in coronavirus disease 2019: an experience from a single large academic center

DVT incidence and risk factors in critically ill patients with COVID-19

Long term respiratory complications of covid-19

Short-and potential long-term adverse health outcomes of COVID-19: a rapid review

Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study

Perioperative SARS-CoV-2 infections increase mortality, pulmonary complications, and thromboembolic events: a Dutch, multicenter, matched-cohort clinical study

Perioperative morbidity and mortality of patients with COVID-19 who undergo urgent and emergent surgical procedures

Factors associated with surgical mortality and complications among patients with and without coronavirus disease 2019 (COVID-19) in Italy

The effects of COVID-19 on perioperative morbidity and mortality in patients with hip fractures

Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study

Association of social and demographic factors with COVID-19 incidence and death rates in the US

Thoracic surgery outcomes for patients with coronavirus disease 2019

Early postoperative outcomes among patients with delayed surgeries after preoperative positive test for SARS-CoV-2: a case-control study from a single institution

Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans

Anesthesia Patient Safety Foundation. COVID-19 and Anesthesia FAQ

Preparing previously COVID-19-positive patients for elective surgery: a framework for preoperative evaluation

Estimating the impact of extended delay to surgery for stage I non-small-cell lung cancer on survival

Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the diamond princess cruise ship

Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis

Prevalence of asymptomatic SARS-CoV-2 infection

The data, technology, and services used in the generation of these research findings were generously supplied pro bono by the COVID-19 Research Database partners, who are acknowledged at https://covid19researchdatabase.org/.